Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, a hair tonic formulation with 25% ethanol extract of mangkokan leaves showed effectiveness in promoting hair growth, as measured by significant differences in hair length and weight compared to the control.

This study reviewed the pharmacological properties of Priyaladi lepa, an Ayurvedic formulation, and reported its potential anti-dandruff benefits due to anti-inflammatory, anti-fungal, anti-microbial, anti-pruritic, antioxidant, and exfoliation effects, warranting further research for managing Darunaka (dandruff).

In a case study, Ayurvedic treatments of leech therapy and topical application of Jayapala beej churna reportedly addressed dosha imbalances associated with Indralupta (Alopecia areata), resulting in new hair growth after several sessions.

This study found that many effects previously thought to be caused by circadian rhythm disruption in Bmal1 knockout mice are actually due to BMAL1's properties unrelated to its clock function.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

In this research, the authors reported that long-term treatment with the JAK1/JAK2 inhibitor baricitinib effectively maintains hair regrowth in patients with severe alopecia areata and may gradually improve outcomes for partial responders over 104 weeks, without increasing side effect incidence.

This review outlines the medicinal uses, phytochemical components, and pharmacological activities of the banana plant but presents no new experimental results.

This study explores how Ayurveda concepts, specifically Prakruti, relate to male pattern baldness, suggesting that individual constitutional types may predict susceptibility to earlier hair loss when influenced by modern lifestyle factors.

This study found that applying a formulation derived from Bacopa procumbens significantly promoted hair growth, pigmentation, and follicular cycle acceleration in mice compared to minoxidil, potentially offering a new therapeutic approach for hair health.

In an outpatient cardiology center, this study found that introducing the AHA/ACC ABI screening protocol significantly increased the frequency of ABI ordering by 31.6% for symptomatic patients.

This abstract introduces baricitinib as an approved treatment for adults with severe alopecia areata in the US, Europe, and Japan, but does not report any specific study results or findings.

This study examined the relationship between blood pressure and alopecia in Belitang, finding a significant association with higher blood pressure among those with alopecia and identifying an elevated risk in the Komering ethnic group, suggesting potential genetic factors.

This study found that the DPP-4 inhibitor linagliptin slowed the progression of premature aging characteristics in klotho-/- mice, including improved body weight, cognitive function, and hair retention.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

This study found that the revised BASP classification for pattern hair loss, which addresses certain limitations of the original, could serve as an alternative option despite a decrease in clinical accuracy and ease of use.

In this case report, a 35-year-old male experiencing hair loss showed improvement with new hair growth after receiving Ayurvedic Rakta Mokshana therapy, including Pracchana and Cupping, within 15 days.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

This review highlights the promising therapeutic potential of Bacopa monnieri in treating various health conditions, particularly related to neuropharmacology, but emphasizes the need for further clinical research.

In this study, researchers identified two significant genetic polymorphisms in the 3'-UTR of the HSP70 gene in Moa buffalo, which may play an important role in heat adaptation, providing insights for conservation and performance improvement in tropical climates.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

In this case study, researchers observed that Ayurvedic treatments, specifically Praccahnna and Tikta Patola patra swarasa Lepa, improved symptoms of alopecia areata, such as reducing patch size and hair fall.

This source reports that based on international Phase 3 trial results, the JAK1/2 inhibitor baricitinib was approved in Japan in June 2022 for treating extensive alopecia areata, offering a potentially useful treatment option.

This source examines alopecia areata, an autoimmune condition causing patchy hair loss, describing the current reliance on corticosteroid injections despite their severe side effects, and explores Ayurvedic treatments identified as Shaman and Shodhan for managing an equivalent condition called Indralupta.

In this case report, researchers described a 6-year-old girl with severe mandibuloacral dysplasia type A, noting unique physical deformities and a rare homozygous LMNA gene mutation not commonly associated with the condition.

This case report documents a middle-aged female with black piedra on her scalp hair, confirmed through potassium hydroxide examination and fungal culture.

This study highlights Ayurveda's holistic approach to managing hair loss, known as Khalitya, through lifestyle changes, purification therapies, and targeted medications, addressing the condition's association with modern sedentary lifestyles and poor dietary habits.

This case report describes a middle-aged woman diagnosed with black piedra of the scalp, confirmed by potassium hydroxide examination and fungal culture.

Eyebrow and eyelash regrowth usually matches scalp hair response in alopecia areata patients treated with baricitinib.